HTB homepage • Conference reports • Articles by subject • Subscribe August 2020 Contents Editorial HTB: no. 10 – HIV and COVID-19: issue 7 (28 August 2020) Conference reports 23rd International AIDS Conference (AIDS 2020): second reports Capsid inhibitor lenacapavir (GS-6207) allows for 6-monthly dosing Weight gain with integrase inhibitors and TAF: three reports from AIDS 2020 Dolutegravir non-inferior to efavirenz at week 96 in the NAMSAL study but associated with substantial weight gain Switching from efavirenz- to dolutegravir-based ART second-line achieved good rates of suppression: first results from the VISEND study Paediatric dolutegravir dosing at AIDS 2020 COVID-19 outcomes in HIV positive people in two large US cohorts AIDS 2020: virtual content now available free and on-demand Pathways to an HIV cure: online presentations Antiretrovirals US FDA approves dolutegravir/lamivudine (Dovato) as switch option EMA extends indication for darunavir/r to include adolescents >12 years ViiV resubmits cabotegravir plus rilpivirine long-acting injections (Cabenuva, Vocabria) to FDA for approval HIV prevention and transmission EMA supports use of dapivirine vaginal ring to prevent HIV in high-incidence countries Other news HIV organisations challenge government proposal to abolish Public Health England On the web Modern ART – community video AVAC web interviews about new treatments to prevent HIV COVID-19: HIV and COVID-19 coinfection HIV associated with worse outcomes from COVID-19 in UK ISARIC and OpenSAFELY databases European and UK doctors review latest studies on HIV and COVID-19 coinfection COVID-19: vaccine research US activists ensure people living with HIV can enrol in COVID-19 vaccine studies HIV organisations oppose active-challenge COVID-19 vaccine studies AVAC webinar with Barney Graham: COVID-19 vaccine targets, timelines, efficacy and ethical issues Equitable access to vaccines against COVID-19 COVID-19: investigational drugs Tocilizumab associated with better outcomes from COVID-19 in US study Famotidine associated with better outcomes from COVID-19 INSIGHT network to study monoclonal antibodies for COVID-19 including LY-CoV555 PDFs HTB no 10 – plus: HIV and COVID-19 bulletin no 7 (28 August 2020) HTB homepage • Conference reports • Articles by subject • Subscribe